Cargando…
Sperm protein 17 targeting for epithelialovarian cancer treatment in the eraof modern immunoengineering
Due to the vague symptomatology of the disease and a lack of effective screening methods, most patients with epithelial ovarian cancer (EOC) present late in their disease. Despite advances in chemotherapeutic agents, the prognosis of these patients has uniformly been extremely poor. Although cisplat...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604669/ https://www.ncbi.nlm.nih.gov/pubmed/34853809 http://dx.doi.org/10.1016/j.omto.2021.10.010 |